IMPACTO DA IMPLANTAÇÃO DO SERVIÇO DE HEMODINÂMICA DO HUGOL NO ESTADO DE GOIÁS NOS CUIDADOS AO PACIENTE COM INFARTO AGUDO DO MIOCÁRDIO
PDF (Português (Brasil))

Keywords

Acute coronary syndromes
epidemiology
impact
reference center
Hugol

How to Cite

Queiroz, L. M., Pereira Neto, J. G., Pereira Santos , V. C., da Fonseca Neto, H. F., Sousa Santana, V., Zaccariotti, A. J., Gomes Pidde , A., Ataides, R. C., de Castro Filho, C. G., Lopes Martins, L., Graner Moreira, H., & Gomes Castro, R. (2023). IMPACTO DA IMPLANTAÇÃO DO SERVIÇO DE HEMODINÂMICA DO HUGOL NO ESTADO DE GOIÁS NOS CUIDADOS AO PACIENTE COM INFARTO AGUDO DO MIOCÁRDIO . Brazilian Journal of Implantology and Health Sciences, 5(5), 4631–4656. https://doi.org/10.36557/2674-8169.2023v5n5p4631-4656

Abstract

Acute Coronary Syndromes (ACS) are projected to cause 23.6 million deaths globally by 2030. In 2008, ACS led to nearly 1 million hospitalizations in Brazil, according to DATASUS. In 2018, the state of Goiás established a reference center for ACS treatment at the Governor Otávio Lage de Siqueira Emergency State Hospital (HUGOL) in Goiânia. This study aimed to assess the impact of implementing the hemodynamics service at HUGOL on ACS patient mortality. The observational, epidemiological, descriptive, and time series study analyzed hospitalization, death, and mortality rates for ACS patients in Goiás from January 2008 to December 2019. Data were collected from the SUS Hospital Information System (SIH/SUS) and Mortality Information System (SIM/SUS). Mortality rates in Goiás and Goiânia showed no reduction, indicating a significant increasing trend (R2 >0.65), with the state's rate surpassing Goiânia's, consistent with literature reporting lower rates in capitals. Notably, there was a significant rise in hospitalizations at both national and international levels. The average cost per patient increased, possibly due to the lack of monetary correction, confirming the global trend of rising expenditures over time. Procedures experienced a significant increase in their performance (R2=0.79), accompanied by a rise in absolute numbers of deaths, while the mortality rate remained stable. Despite the implementation of the Hemodynamics Service at HUGOL in Goiânia, ACS mortality rates in Goiás and Goiânia continued to exhibit an increasing trend. This suggests that the intensified use of invasive procedures has not yet been sufficient to alter the epidemiology of these diseases in the state.

https://doi.org/10.36557/2674-8169.2023v5n5p4631-4656
PDF (Português (Brasil))

References

ALMEIDA, M. C. et al. Comparação do Perfil Clínico-Epidemiológico entre Homens e Mulheres na Síndrome Coronariana Aguda. Revista Brasileira de Cardiologia, v. 27, n. 6, p. 423–429, 2014.

ANDERSON, H.V. et al. A contemporary overview of percutaneous coronary interventions. The American College of CardiologyNational Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol. 2002; 39(7): 1096-1103

BASSAN, F; BASSAN, R. Abordagem da síndrome coronariana aguda. Revista da Sociedade de Cardiologia do Rio Grande do Sul Jan/Fev/Mar/Abr 2006; 15(7):1-6.

BLOOM. D, et al. The Global Economic Burden of Non-communicable Diseases. World Economic Forum: Geneva, 2011. Disponível em: <http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf>. Acesso em: 26. jun. 2019

CHAGAS, J. P. A. et al. A importância do atendimento no tempo correto para pacientes com infarto agudo do miocárdio.Revista Brasileira de Ciências da Vida, [S.l.], v. 6, n. 3, abr. 2018.

DÉGANO, I.R. et al. Epidemiology of Acute Coronary Syndromes in Spain: Estimation of the number of Cases and Trends From 2005 to 2049. Rev Esp Cardiol. 2013;66(6):472–481 473

DE MULDER, M. et al. EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. European Heart Journal. 2011; 32(11): 1398-1408.

FRANCO, M.A.E. et al. Impacto econômico da morbimortalidade hospitalar por infarto agudo do miocárdio em idosos no Brasil. Brazilian Journal of Health Review. Volume 3, número 6. 2020. ISSN: 2595-6825.

GACH O.; HUSSEINI E.l.; LANCELOTTI P. Syndrome coronarien aigu. Rev Med Liege. 2018 Maio;73(5-6):243-250. French.

GAUI, E. N.; KLEIN, C. H.; OLIVEIRA, G. M. M. DE. Proportional Mortality due to Heart Failure and Ischemic Heart Diseases in the Brazilian Regions from 2004 to 2011. Arquivos Brasileiros de Cardiologia, 2016.

GAUI, E. N.; OLIVEIRA, G. M. M. DE; KLEIN, C. H. Mortality by Heart Failure and Ischemic Heart Disease in Brazil from 1996 to 2011. Arquivos Brasileiros de Cardiologia, p. 557–565, 2014.

JAN, S. et al. Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia. BMC Cardiovasc Disord. 2018;

LEIVA, E.H. Epidemiología del síndrome coronario agudo y la insuficiencia cardiaca en Latinoamérica, Revista Española de Cardiología, Volume 64, Supplement 2,2011, Pages 34-43, ISSN 0300-8932, https://doi.org/10.1016/j.recesp.2011.01.022.

LORENZO, A. DE. Gender Disparities and Outcomes Of Acute Coronary Syndromes In Brazil. Arquivos Brasileiros de Cardiologia, p. 654–655, 2018.

MAGEE, R. F. et al. Revista de Medicina e Saúde de Brasília ARTIGO DE REVISÃO Síndrome Coronariana Aguda: uma revisão. Rev Med Saude Brasilia, v. 1, n. 3, p. 174–89, 2012.

MARINO, B. C. A. et al. Epidemiological Profile and Quality Indicators in Patients with Acute Coronary Syndrome in Northern Minas Gerais - Minas Telecardio 2 Project. Arquivos Brasileiros de Cardiologia. v. 107, n. 2; 2016.

SANCHIS-GOMAR, F. et al. Epidemiology of coronary heart disease and acute coronary syndrome. Annals of Translational Medicine, v. 4, n. 13, p. 256–256, jul. 2016.

SANCHO, A. G. et al. A significância da Avaliação Intra-Hospitalar da Capacidade Funcional na Síndrome Coronariana Aguda. Rev Bras Cardiol., v. 24, n. 5, p. 282–290, 2011.

SILVA, A. J. DOS S.; GUIMARÃES, C. S. S.; REIS, J. Á. Profile of patients admitted to hospital – with diagnosis of acute coronary syndrome. n. 61, 2018.

SILVA, L. N. et al. Clinical and epidemiological profile of patients with acute coronary syndrome. Revista de Enfermagem da UFPI, v. 3, n. 2, p. 78, 2014.

SOEIRO, A. DE M. et al. Prognostic Differences between Men and Women with Acute Coronary Syndrome. Data from a Brazilian Registry. Arquivos Brasileiros de Cardiologia, 2018.

TEICH, V. et al. Estimativa de Custo da Síndrome Coronariana Aguda no Brasil. Rev Bras Cardiol, 24(2):85-94, 2011.

Uva MS, Freitas S, Pedro A, Matias F, Mesquita A, Bau J et al. Cirurgia de bypass coronário off-pump na mulher. Rev Port Cardiol. 2009; 28: 813-824.

SHAW et al. COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation, v. 117, n. 10, p. 1283-1291, 2008.

DAVIES et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation, v. 95, n. 8, p. 2037-2043, 1997.

ANDERSON et al. ACC/AHA Guidelines for the Management of Patients With Unstable Angina/NonST-Elevation Myocardial Infarction. Circulation, v. 116, p. 803-877, 2007.

BASSAND et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. European Heart Journal, v. 28, p. 1598-1660, 2007.

SIGWART et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. New England Journal of Medicine, v. 316, n. 12, p. 701-706, 1987.

MORICE et al. RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. Surgical Neurology v. 59, n. 3 p. 146-147, 2003.

KATRITSIS, IOANNIDIS. Percutaneous coronary intervention versus conservative therapy

in nonacute coronary artery disease: a meta-analysis. Circulation, v. 111, n.22, p.2906-2912, 2005.

KEELEY, BOURA, GRINES. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet, v. 361, p. 13-20, 2003.

GRINES et al. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. American Heart Journal, v. 145, n. 1, p. 48-57, 2003.

MOVAHED et al. Decreasing inhospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the United States. Journal of Invasive Cardiology, v. 22, n. 2, p. 58-60, 2010.

MOVAHED et al. Nationwide trends in the utilization of multivessel percutaneous coronary intervention (MVPCI) in the United States across different gender and ethniticities. Journal of Interventional Cardiology, n. 22, v. 3, p. 247-251, 2009.

WINDECKER et al. Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal, v. 35, n. 37, p. 25, 2014.

MORAZ, Gabriele et al. Estudos de custo-efetividade em saúde no Brasil: uma revisão sistemática. Revista Ciência & Saúde Coletiva, v. 20, n. 10, 2015.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Lais Martins Queiroz, Jaime Garcia Pereira Neto, Vinicius Catenassi Pereira Santos , Hugo Francisco da Fonseca Neto, Vinícius Sousa Santana, Alice Jardim Zaccariotti, Arthur Gomes Pidde , Rafael Caetano Ataides, Celso Gonçalves de Castro Filho, Lucca Lopes Martins, Humberto Graner Moreira, Renato Gomes Castro